Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.
At Iovance Biotherapeutics, the Manager, TIL Therapy Case Management (Individual Contributor) plays a critical role in supporting patients navigating treatment with tumor-infiltrating lymphocyte (TIL) therapies, including Amtagvi. This position is a senior individual contributor responsible for managing complex, time-sensitive patient cases and serving as a subject matter expert on TIL therapy workflows. The role partners closely with patients, caregivers, and authorized treatment centers to coordinate each step of the treatment journey—from tumor procurement through infusio... Click Apply to read the full job description.